Focal therapy for localized prostate cancer: Where do we stand?

Bruno Nahar, Dipen J Parekh

Research output: Contribution to journalComment/debate

Abstract

Focal therapy for localized prostate cancer has emerged as an alternative to whole-gland treatment given its superior side-effects profile and acceptable short-term cancer control. Here we summarize the most relevant evidence related to each focal therapy modality.

Original languageEnglish (US)
JournalEuropean Urology Focus
DOIs
StatePublished - Jan 1 2019

Fingerprint

Prostatic Neoplasms
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Focal therapy for localized prostate cancer : Where do we stand? / Nahar, Bruno; Parekh, Dipen J.

In: European Urology Focus, 01.01.2019.

Research output: Contribution to journalComment/debate

@article{2c5f286fd3b840de82bb3b35e2b4011f,
title = "Focal therapy for localized prostate cancer: Where do we stand?",
abstract = "Focal therapy for localized prostate cancer has emerged as an alternative to whole-gland treatment given its superior side-effects profile and acceptable short-term cancer control. Here we summarize the most relevant evidence related to each focal therapy modality.",
author = "Bruno Nahar and Parekh, {Dipen J}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.euf.2019.04.012",
language = "English (US)",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Focal therapy for localized prostate cancer

T2 - Where do we stand?

AU - Nahar, Bruno

AU - Parekh, Dipen J

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Focal therapy for localized prostate cancer has emerged as an alternative to whole-gland treatment given its superior side-effects profile and acceptable short-term cancer control. Here we summarize the most relevant evidence related to each focal therapy modality.

AB - Focal therapy for localized prostate cancer has emerged as an alternative to whole-gland treatment given its superior side-effects profile and acceptable short-term cancer control. Here we summarize the most relevant evidence related to each focal therapy modality.

UR - http://www.scopus.com/inward/record.url?scp=85064856221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064856221&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2019.04.012

DO - 10.1016/j.euf.2019.04.012

M3 - Comment/debate

AN - SCOPUS:85064856221

JO - European Urology Focus

JF - European Urology Focus

SN - 2405-4569

ER -